121 related articles for article (PubMed ID: 29549850)
21. Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma.
Facciorusso A; Mariani L; Sposito C; Spreafico C; Bongini M; Morosi C; Cascella T; Marchianò A; Camerini T; Bhoori S; Brunero F; Barone M; Mazzaferro V
J Gastroenterol Hepatol; 2016 Mar; 31(3):645-53. PubMed ID: 26331807
[TBL] [Abstract][Full Text] [Related]
22. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
[TBL] [Abstract][Full Text] [Related]
23. Alanine aminotransferase to hemoglobin ratio is an indicator for disease progression for hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization.
Lin ZH; Li X; Hong YF; Ma XK; Wu DH; Huang M; Chen ZH; Chen J; Dong M; Wei L; Wang TT; Ruan DY; Lin ZX; Zhong X; Xing YF; Wen JY; Wu XY; Lin Q
Tumour Biol; 2016 Mar; 37(3):2951-9. PubMed ID: 26411670
[TBL] [Abstract][Full Text] [Related]
24. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare Beneficiaries.
Sanoff HK; Chang Y; Stavas JM; Stürmer T; Lund J
J Natl Compr Canc Netw; 2015 Sep; 13(9):1102-10. PubMed ID: 26358794
[TBL] [Abstract][Full Text] [Related]
26. Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact.
Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Kokudo N; Makuuchi M;
Ann Surg; 2014 Feb; 259(2):336-45. PubMed ID: 23673768
[TBL] [Abstract][Full Text] [Related]
27. Serum gamma-glutamyl-transferase independently predicts outcome after transarterial chemoembolization of hepatocellular carcinoma: external validation.
Guiu B; Deschamps F; Boulin M; Boige V; Malka D; Ducreux M; Hillon P; de Baère T
Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1102-8. PubMed ID: 22009578
[TBL] [Abstract][Full Text] [Related]
28. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
[TBL] [Abstract][Full Text] [Related]
29. Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Huo YR; Eslick GD
JAMA Oncol; 2015 Sep; 1(6):756-65. PubMed ID: 26182200
[TBL] [Abstract][Full Text] [Related]
30. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
Hirooka M; Hiraoka A; Ochi H; Kisaka Y; Joko K; Michitaka K; Hiasa Y
AJR Am J Roentgenol; 2018 Apr; 210(4):891-898. PubMed ID: 29412017
[TBL] [Abstract][Full Text] [Related]
31. Predictors of long-term survival in hepatocellular carcinomas: A longitudinal follow-up of 108 patients with small tumors.
Chang HC; Lin YM; Yen AM; Chen SL; Wu WY; Chiu SY; Fann JC; Lin YS; Chen HH; Liao CS
Anticancer Res; 2013 Nov; 33(11):5171-8. PubMed ID: 24222166
[TBL] [Abstract][Full Text] [Related]
32. Supplemental transcatheter arterial chemoembolization for hepatocellular carcinoma fed by collateral omental artery.
Jia Z; Tian F; Li S; Wang K; Zhao J; Wang Y; Jiang L; Jiang G; Li M
Hepatogastroenterology; 2014 Oct; 61(135):2042-6. PubMed ID: 25713908
[TBL] [Abstract][Full Text] [Related]
33. Lens culinaris agglutinin-reactive alpha-fetoprotein as a prognostic marker in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
Song BC; Suh DJ; Yang SH; Lee HC; Chung YH; Sung KB; Lee YS
J Clin Gastroenterol; 2002; 35(5):398-402. PubMed ID: 12394228
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting.
Zhang XB; Wang JH; Yan ZP; Qian S; Liu R
Cardiovasc Intervent Radiol; 2009 Jan; 32(1):52-61. PubMed ID: 18931871
[TBL] [Abstract][Full Text] [Related]
35. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
36. Early treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma.
Lee SW; Lee HL; Han NI; Jang JW; Bae SH; Choi JY; Yoon SK
Cancer Chemother Pharmacol; 2017 Jan; 79(1):81-88. PubMed ID: 27913882
[TBL] [Abstract][Full Text] [Related]
37. Transcatheter arterial chemoembolization with an interventional-CT system for recurrent hepatocellular carcinoma after living donor liver transplantation.
Yamagami T; Yoshimatsu R; Ishikawa M; Kajiwara K; Aikata H; Tashiro H; Kakizawa H; Toyoda N; Ohdan H; Awai K
Hepatogastroenterology; 2014; 61(133):1387-92. PubMed ID: 25436316
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of chemoembolization for recurrent HCC after curative ablation therapy.
Okabe N; Morimoto M; Kondo M; Moriya S; Numata K; Maeda S; Tanaka K
Hepatogastroenterology; 2013 May; 60(123):395-99. PubMed ID: 23108088
[TBL] [Abstract][Full Text] [Related]
39. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
Fan J; Wu Z; Tang Z
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma: high hepatitis B viral load and mortality in patients treated with transarterial chemoembolization.
Yu SJ; Lee JH; Jang ES; Cho EJ; Kwak MS; Yoon JH; Lee HS; Kim CY; Kim YJ
Radiology; 2013 May; 267(2):638-47. PubMed ID: 23440326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]